Gilead Sciences, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, California

Insiders trading volume in the past year

Gilead Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel P. O'Day Chairman & CEO, Director $40.2 M Jun 10, 2024
Andrew D. Dickinson Chief Financial Officer $11.7 M -$1.23 M -9.49% Jun 10, 2024
Johanna Mercier Chief Commercial Officer $10.7 M -$702 K -6.15% Jun 10, 2024
Merdad Parsey Chief Medical Officer $9.51 M -$1.14 M -10.7% Jul 1, 2024
Olsen Per Wold Director $8.75 M May 6, 2021
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel $4.17 M Jun 10, 2022
Diane E. Wilfong SVP, Controller & CAO $3.62 M Feb 6, 2023
Deborah H. Telman EVP, Corporate Affairs & GC $3.48 M Jun 10, 2024
Sandra Patterson SVP, Controllership $3.33 M Jun 10, 2024
Richard James Whitley Director $3.15 M May 6, 2021
Jacqueline K. Barton Director $1.59 M May 8, 2024
Kelly A. Kramer Director $1.15 M May 8, 2024
Harish Manwani Director $836 K May 8, 2024
Javier Rodriguez Director $695 K May 8, 2024
Anthony Welters Director $664 K May 8, 2024
Sandra Horning Director $509 K May 8, 2024
Jeffrey Bluestone Director $274 K May 8, 2024
Ted W. Love Director $183 K May 8, 2024
Kevin E. Lofton Director Mar 28, 2024

Recent Insider Transactions by Companies or Individuals for Gilead Sciences, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership